Type I SMA patients have two SMN2 copies and present with symptoms within the first 6 months, type II patients have three copies and present with symptoms by 18 months, while type III patients have 3-4 SMN2 copies with later onset. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.